-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HsLJpnECF3P9uKOfzc0Wj60vuxlnzSWD6ivbtOhj0OIG/xAnHecFlctx71MNVFQd niO7cWusrdb+YCBGIUIWQw== 0000842325-97-000009.txt : 19970225 0000842325-97-000009.hdr.sgml : 19970225 ACCESSION NUMBER: 0000842325-97-000009 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19970205 SROS: NASD GROUP MEMBERS: BLAIR D H & CO INC/NY/ GROUP MEMBERS: KENTON E. WOOD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PANAX PHARMACEUTICAL CO LTD CENTRAL INDEX KEY: 0000929547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133754005 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-47845 FILM NUMBER: 97518418 BUSINESS ADDRESS: STREET 1: 425 PARK AVE STREET 2: 27TH FL CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123198300 MAIL ADDRESS: STREET 1: 425 PARK AVE STREET 2: 27TH FL CITY: NEW YORK STATE: NY ZIP: 10022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BLAIR D H & CO INC/NY/ CENTRAL INDEX KEY: 0000842325 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 132797175 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 44 WALL ST CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 2129682000 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.___________)* Panax Pharmaceutical Company, Ltd. ----------------------------------------------------- (Name of Issuer) Common Stock, $.0001 par value ------------------------------------------------------------- (Title of Class of Securities) 69830P105 ----------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 69830P105 13G Page 2 of 6 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON D.H. Blair & Co., Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 320,000 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 0 REPORTING -------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 320,000 -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 320,000 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.3% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 69830P105 13G Page 3 of 6 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Kenton Wood - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Great Britain - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 320,000 REPORTING -------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 0 -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 320,000 - ---------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 320,000 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.3% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Page 4 of 6 pages Item 1. (a) Name of Issuer: Panax Pharmaceutical Company, Ltd. (b) Address of Issuer's Principal Executive Offices: 425 Park Avenue, 27th Floor New York, NY 10022 Item 2. (a) Name of Person Filing: This statement is filed jointly by D.H. Blair & Co., Inc. ("Blair") and Kenton E. Wood ("Wood") (together, the "Reporting Parties"). Wood is Chairman and Chief Executive Officer of Blair. See attached Exhibit A which is a copy of their agreement in writing to file this statement on behalf of each of them. (b) Address of Principal Business Office or, if None, Residence: The Reporting Parties' business address is 44 Wall Street, New York, NY 10005. (c) Citizen: Blair is incorporated in the State of New York and Wood is a citizen of Great Britain. (d) Title of Class of Securities: Common Stock, $.0001 par value ("shares"). (e) CUSIP#: 69830P105 Item 3. (a) Blair is a broker-dealer registered under Section 15 of the Securities Exchange Act. Item 4. Ownership: (a) (b) As of December 31, 1996, the Reporting Parties may be deemed to beneficially own 320,000 shares or 9.3% of the Issuer's shares issued and outstanding, underlying a warrant (the "Warrant") to purchase 320,000 shares at a price of $1.00 per share, exercisable through October 2, 2000, held by Blair. (c) Wood, as Chairman of the Board of Directors of Blair, shares voting and dispositive power over securities owned by Blair with its Board of Directors. Item 5. Ownership of Five Percent or Less of a Class: Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable. Item 8. Identification and Classification of Members of the Group: Not applicable. Item 9. Notice of Dissolution of Group: Not applicable. Page 5 of 6 pages Item 10. Certification: By signing below we certify that to the best of our knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as participant in any transaction having such purpose of effect. EXHIBIT INDEX ------------- EXHIBIT A - Agreement by the Reporting Parties to file this Schedule 13G on behalf of each of them. SIGNATURES After reasonable inquiry and to the best knowledge and belief of the Reporting Persons, each such person or entity certifies that the information set forth in this statement is true, complete and correct. D.H. BLAIR & CO., INC. /s/ Kenton E. Wood Dated: February 3, 1997 By:________________________________ New York, New York Kenton E. Wood Chairman /s/ Kenton E. Wood Dated: February 3, 1997 _________________________________ New York, New York Kenton E. Wood EX-99 2 AGREEMENT Page 6 of 6 Pages EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13G and any future amendments thereto reporting each of the undersigned's ownership of securities of Panax Pharmaceutical Corp., Ltd., and hereby affirm that such Schedule 13G is being filed on behalf of each of the undersigned. D.H. BLAIR & CO., INC. /s/ Kenton E. Wood Dated: February 3, 1997 By:________________________________ New York, New York Kenton E. Wood Chairman /s/ Kenton E. Wood Dated: February 3, 1997 _________________________________ New York, New York Kenton E. Wood -----END PRIVACY-ENHANCED MESSAGE-----